Quick Answer
IDEXX LABORATORIES INC /DE reported Long Term Debt of $374.84 million for the year ending 2025.
- IDEXX LABORATORIES INC /DE showed a decrease of -16.7% in Long Term Debt from 2024 to 2025.
- This data is from IDEXX LABORATORIES INC /DE's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $853.32 million | Q1 2021: $778.75 million | Q2 2021: $780.08 million | Q3 2021: $778.03 million | Q1 2022: $773.38 million | Q2 2022: $768.00 million | Q3 2022: $760.81 million | Q1 2023: $696.36 million | Q2 2023: $696.84 million | Q3 2023: $618.81 million | Q1 2024: $620.78 million | Q2 2024: $524.74 million | Q3 2024: $524.76 million | Q1 2025: $449.80 million | Q2 2025: $449.81 million | Q3 2025: $374.83 million.
- Over the full 7 years of available data (2019 to 2025), IDEXX LABORATORIES INC /DE's Long Term Debt has declined by 46.4%.
- Historical annual values: Fiscal year 2025: $374.84 million | Fiscal year 2024: $449.79 million | Fiscal year 2023: $622.88 million | Fiscal year 2022: $694.39 million | Fiscal year 2021: $775.21 million | Fiscal year 2020: $858.49 million | Fiscal year 2019: $698.91 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: